TALDO1 and prostate carcinoma: Cancer cells increase their expression of TKT and TALDO to accelerate the nonoxidative branch of the PPP [49], with elevated levels of TKT reported in lung, breast, and prostate cancer cells [52,61,62,63], and elevated levels of TALDO reported in gastric adenocarcinoma [64].